机构地区:[1]天津中医药大学中医药研究院,天津300913 [2]天津中医药大学天津市现代中药重点实验室,天津300913 [3]天津中医药大学中西医结合学院,天津300913
出 处:《中国临床药理学杂志》2018年第15期1835-1838,共4页The Chinese Journal of Clinical Pharmacology
基 金:国家自然科学基金资助项目(81603329);国家国际科技合作专项基金资助项目(2015DFA30430);新世纪优秀人才支持计划基金资助项目(NNCET13-09-35);天津市自然科学基金资助项目(16JCZDJC36300)
摘 要:目的探究脑心通胶囊(NXT)对心肌缺血大鼠血小板聚集及凝血功能的影响。方法 120只Wistar雄性大鼠随机分为假手术组、模型组和低、中、高剂量实验组(脑心通0.25,0.5,1 g·kg^(-1)·d^(-1)),以及阳性对照组(阿司匹林10mg·kg^(-1)·d^(-1)),其中60只连续灌胃预给药14 d,结扎冠状动脉制备心肌缺血模型。术后24 h,腹主动脉取血,分离血小板,检测10μmol·L^(-1)腺苷二磷酸(ADP)诱导的血小板聚集率。其余60只无预给药,术后给药3 d。术后24 h及术后给药3 d,分离血浆,用半自动血凝仪检测活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、凝血酶时间(TT)和纤维蛋白原(FIB)。用酶联免疫吸附法(ELISA)测定血浆中血栓素B2(TXB2)、6-酮-前列腺素F1α(6-ketoPGF1α)、组织纤溶酶原激活物(t-PA)和I型纤溶酶原激活抑制因子(PAI^(-1))的表达。结果模型组与高剂量实验组ADP诱导的血小板聚集率分别为(23.90±8.32)%和(10.84±3.42)%,差异有统计学意义(P<0.05);模型组、高剂量实验组的APTT分别为(15.20±1.62),(25.40±5.97)s;PT分别为(34.50±3.58),(39.10±2.05)s;TT分别为(14.59±0.85),(22.90±1.63)s,差异均有统计学意义(P<0.05,P<0.01)。模型组、高剂量实验组血浆中TXB2分别为(102.61±10.26),(44.00±6.21)pg·m L^(-1);6-keto-PGF_(1α)分别为(12.50±2.17),(28.48±5.50)pg·m L^(-1);t-PA分别为(0.83±0.20),(1.53±0.26)ng·m L^(-1);PAI^(-1)分别为(6.63±0.74),(3.67±0.41)ng·m L^(-1),差异均有统计学意义(P<0.05,P<0.01)。结论脑心通胶囊可以抑制心肌缺血大鼠血小板的聚集率,延长凝血时间,改善血液高凝状态,保护缺血心肌组织。Objective To study the effect of Naoxintong capsule( NXT)on platelet aggregation and coagulation function in rats with myocardial ischemia. Methods A total of 120 male Wistar rats were randomly divided into six groups: sham group,model group,low-dose group( 0. 25 g·kg^(-1)·d^(-1) NXT), medium-dose group( 0. 5 g · kg^(-1)· d^(-1) NXT),high-dose group( 1 g · kg^(-1)· d^(-1) NXT),positive control group( 10 mg·kg^(-1)·d^(-1) aspirin). Drugs were orally administered to60 rats for 14 days. Myocardial ischemic( MI) rat model was established by ligation of the anterior descending coronary artery. Blood was obtained from the abdominal aorta at 24 hours after myocardial ischemia. Plateletswere isolated and 10 μmol·L^(-1) adenosine diphosphate( ADP)-induced-platelet aggregation rate was detected. And the other 60 rats were not pretreated and drugs were orally administered for 3 days after MI. Activated partial thromboplastin time( APTT),prothrombin time( PT),thrombin time( TT) and fibrinogen( FIB) concentration were detected using semi-automated blood coagulation analyzer at 24 h and 3 days after MI. And the expression of thromboxane B2( TXB2),6-keto-PGF1α,tissue plasminogen activator( t-PA),plasminogen activator inhibitor 1( PAI^(-1)) in the plasma was detected using ELISA kits. Results There were significant differences between the model group and the high-dose group in platelet aggregation rate [( 23. 90 ± 8. 32) % vs( 10. 84 ± 3. 42) % ],APTT[( 15. 20 ± 1. 62) s vs( 25. 40 ±5. 97) s],PT[( 34. 50 ± 3. 58) s vs( 39. 10 ± 2. 05) s],TT[( 14. 59 ± 0. 85) s vs( 22. 90 ± 1. 63) s],the expression of TXB2[( 102. 61 ± 10. 26) pg·m L^(-1) vs( 44. 00 ± 6. 21) pg·m L^(-1)],6-keto-PGF_(1α)[( 12. 50 ± 2. 17)pg·m L^(-1) vs( 28. 48 ± 5. 50) pg·m L^(-1)],t-PA[( 0. 83 ± 0. 20) ng·m L^(-1) vs( 1. 53 ± 0. 26) ng·m L^(-1)],PAI^(-
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...